$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Duodenum-preserving pancreatic head resection (DPPHR) was first reported by Beger and colleagues in 1972 to treat chronic pancreatitis1. To treat benign or low-grade malignant tumors of the pancreatic head, a more extensive procedure known as duodenum-preserving total pancreatic head resection (DPPHRt) was developed in 19882. This technique provides an alternative to conventional pancreaticoduodenectomy (PD) and may include segmental resection of the duodenum and common bile duct when necessary3.
Intraductal papillary mucinous neoplasm (IPMN) is a major subtype of pancreatic cystic neoplasms (PCNs) and is widely recognized as a precursor lesion to pancreatic cancer. Surgical resection remains one of the primary treatment strategies for IPMNs, with current guidelines recommending intervention based on the presence of high-risk stigmata or worrisome features4. However, for benign or low-grade malignant lesions restricted to the pancreatic head, with a diameter of no more than 5 cm, especially in patients under 70 years old, the optimal surgical procedure remains uncertain.
The advantages of DPPHR over conventional PD are evident not only in reduced early postoperative complications, but also in better long-term quality of life (QoL)3,5,6,7. For long-term function, DPPHR has advantages over PD in terms of a lower incidence of metabolic dysfunctions7,8. With the advancement of minimally invasive surgery, robotic surgical systems are increasingly adopted due to their enhanced dexterity, tremor filtration, high-definition visualization, reduced intraoperative bleeding, and faster postoperative recovery9. As indicated by recent research, robotic DPPHR (R-DPPHR) has strengths in conserving both exocrine and endocrine pancreatic functions, with the aid of intraoperative indocyanine green (ICG) fluorescence imaging10,11.
In this report, we present a case of a 65-year-old male patient diagnosed with a main duct IPMN (MD-IPMN) of the pancreatic head. The patient underwent successful R-DPPHRt. This report aims to illustrate the feasibility and clinical advantages of R-DPPHRt in the management of pancreatic head IPMN, and to explore its potential indications in patients with benign or borderline tumors in the pancreatic head. Robotic duodenum-preserving total pancreatic head resection offers an organ-preserving alternative to pancreaticoduodenectomy, particularly for selected patients with IPMNs.